Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Balfour

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Drugs|October 1, 1994
Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disordersH A Friedel, J A Balfour
Drugs|April 8, 1999
FomivirsenC M Perry, J A Balfour
Drugs|May 1, 1994
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacyL R Wiseman, J A Balfour
Drugs & Aging|February 1, 1994
Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderlyL R Wiseman, J A Balfour
Drugs & Aging|May 1, 1997
Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertensionJ A Balfour, M I Wilde
Drugs|August 1, 1991
Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain statesJ A Balfour, M M Buckley
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Combination hepatitis a-hepatitis B vaccineA J Wagstaff, J A Balfour
Clinical Otolaryngology and Allied Sciences|April 12, 2003
Informed consent for middle ear operations: a United Kingdom surveyN Saravanappa, A Balfour, D Bowdler
Drugs|December 1, 1994
Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain statesC R Lee, J A Balfour
Drugs & Aging|May 8, 1998
RaloxifeneJ A Balfour, K L Goa
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Drugs|October 1, 1994
Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disordersH A Friedel, J A Balfour
Drugs|April 8, 1999
FomivirsenC M Perry, J A Balfour
Drugs|May 1, 1994
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacyL R Wiseman, J A Balfour
Drugs & Aging|February 1, 1994
Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderlyL R Wiseman, J A Balfour
Drugs & Aging|May 1, 1997
Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertensionJ A Balfour, M I Wilde
Drugs|August 1, 1991
Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain statesJ A Balfour, M M Buckley
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Combination hepatitis a-hepatitis B vaccineA J Wagstaff, J A Balfour
Clinical Otolaryngology and Allied Sciences|April 12, 2003
Informed consent for middle ear operations: a United Kingdom surveyN Saravanappa, A Balfour, D Bowdler
Drugs|December 1, 1994
Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain statesC R Lee, J A Balfour
Drugs & Aging|May 8, 1998
RaloxifeneJ A Balfour, K L Goa
Pageof 11